EP3302507
DIAGNOSTIC METHODS FOR T CELL THERAPY
:
EP einkaleyfi: Þýðing ekki lögð inn:
27.5.2016:
22.2.2023:
16800846.4
:
26.5.2036
:
DIAGNOSTIC METHODS FOR T CELL THERAPY
27.5.2016
22.2.2023
:
The United States of America, as represented by The Secretary, Department of Health and Human Services:
Office of Technology Transfer National Institutes of Health 6011 Executive Boulevard, Suite 325 MSC 7660, Bethesda, MD 20892-7660, US
:
Kite Pharma, Inc.:
2225 Colorado Ave., Santa Monica, CA 90404, US
:
BOT, Adrian:
California 90404, US
:
WIEZOREK, Jeffrey S.:
California 90404, US
:
GO, William:
California 90404, US
:
JAIN, Rajul:
California 90404, US
:
KOCHENDERFER, James N.:
Bethesda, Maryland 20892, US
:
ROSENBERG, Steven A.:
Bethesda, Maryland 20892, US
:
201562167738 P:
28.5.2015:
US
:
201562262111 P:
2.12.2015:
US
:
US2016034885:
27.5.2016
:
A61K 35/17, A61K 38/20, C12N 5/0783, C12N 5/10, C12N 15/19, C12N 15/24, A61K 31/00, C07K 14/52, C07K 14/00, C12N 15/00, G01N 33/68, A61P 35/00, A61K 31/095, A61K 31/445, A61K 31/52, A61K 31/665, A61K 39/00, C07K 14/725